Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

LSE:COG Falls 3.03%: Cambridge Cognition Targets Healthcare, Consumer Wellness and AI-Driven Brain Health Growth

• Cambridge Cognition Holdings PLC (LSE:COG) fell 3.03% on August 21, 2026, closing at 31p compared with 32p previously.

Ankur Sharma | 24 August 2026

Hemogenyx Shares Fall 6.60% as HG-CT-1 CAR-T Commercialisation Moves Into Focus

Hemogenyx Pharmaceuticals became a notable healthcare stock in focus on21 August 2026, whenLSE:HEMO shares fell 6.60% to 594p.

Ankur Sharma | 24 August 2026

Diaceutics Shares Retreat — Healthcare-Tech Investors Turn Cautious

Diaceutics has been one of AIM's more resilient healthcare-technology names in 2026, but its shares have slipped back after a strong run — a reminder that even improving stories are not immune to profit-taking. Investors are weighing a sharp acceleration inRecurring Revenueagainst a still-modest …

Ankur Sharma | 21 August 2026

ProBiotix Health Shares Fall — Investors Cool on the Microbiome Growth Story

ProBiotix Health, the Aquis-quoted developer of the cholesterol-lowering LP-LDL probiotic strain, slipped even as its accounts showed theBusinessturning profitable — a reminder that thinly traded micro-cap prices can drift regardless of the underlying trading story.

Ankur Sharma | 21 August 2026

Why Is Oxford BioDynamics PLC LSE:OBD in Focus Amid investor focus on its epigenetic biomarker tests and the pace of commercial adoption?

Oxford BioDynamics PLC — LSE:OBD is attracting investor attention amidinvestor focus on its epigenetic biomarker tests and the pace of commercial adoption.

Ishan Mudgal | 21 August 2026

Why Is Physiomics PLC LSE:PYC in Focus Amid investor focus on its computational modelling services and its pharmaceutical customer contracts?

Physiomics PLC — LSE:PYC is attracting investor attention amidinvestor focus on its computational modelling services and its pharmaceutical customer contracts.

Ishan Mudgal | 21 August 2026

Why Is Solvonis Therapeutics PLC LSE:SVNS in Focus Amid investor focus on its therapeutics pipeline targeting mental health and substance use disorders?

Solvonis Therapeutics PLC — LSE:SVNS is attracting investor attention amidinvestor focus on its therapeutics pipeline targeting mental health and substance use disorders.

Ishan Mudgal | 21 August 2026

Why Is Surgical Innovations Group PLC LSE:SUN in Focus Amid investor focus on its surgical instrument sales and its contract manufacturing work?

Surgical Innovations Group PLC — LSE:SUN is attracting investor attention amidinvestor focus on its surgical instrument sales and its contract manufacturing work.

Ishan Mudgal | 21 August 2026

Why Is TheraCryf PLC LSE:TCF in Focus Amid investor focus on its clinical-stage pipeline and its partnering discussions?

TheraCryf PLC — LSE:TCF is attracting investor attention amidinvestor focus on its clinical-stage pipeline and its partnering discussions.

Ishan Mudgal | 21 August 2026

Why Is ValiRx PLC LSE:VAL in Focus Amid investor focus on its oncology and women’s health development programmes?

ValiRx PLC — LSE:VAL is attracting investor attention amidinvestor focus on its oncology and women’s health development programmes.

Ishan Mudgal | 21 August 2026
Support

Hi! How can we help you today?

Loading…